LSE:NCYT (Novacyt S.A.)
About NCYT
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. Its diagnostic products are used in LBC, oncology, microbiology, hematology, and serology testing. The company operates its business through the following business segments. Primerdesign is the designer, manufacturer, and marketer of molecular 'real-time' qPCR testing devices and reagents in the areas of infectious diseases based in Southampton, UK: Lab21 Product segment is a developer, manufacturer, and distributor of a large range of protein-based infectious disease IVD products; IT-IS International segment develops PCR devices for the life sciences and food testing industry and Corporate segment.
Novacyt S.A. (LSE: NCYT) Latest News
Investing Articles
The Novacyt share price just slumped! Here’s why?
Investing Articles
Is the Novacyt (LON:NCYT) share price now a screaming buy?
Investing Articles
The Novacyt share price is down 77% in a year – is it now a glaring buy?
Investing Articles
The Novacyt (LON:NCYT) share price continues to tumble on delays
Investing Articles
Is this why the Novacyt share price keeps falling?
Investing Articles
What’s going on with the Novacyt (NCYT) share price?
Investing Articles
3 dirt-cheap AIM stocks. Should I buy?
![Syringe and vial on blue background](https://www.fool.co.uk/wp-content/uploads/2020/11/Vaccine-400x225.jpg)
Investing Articles
The Novacyt (NCYT) share price: is it set to soar again?
Investing Articles
Is the Novacyt (NCYT) share price about to bounce back?
Investing Articles
Should I buy Novacyt shares at under 400p?
![Woman sneaker shoe and Arrow on street with copy space background](https://www.fool.co.uk/wp-content/uploads/2020/12/StartHere1-400x225.jpg)